XM无法为美国居民提供服务。
S
S

Sanofi


市场新闻

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Secureworks, Atlantic Union Bankshares, Catalent, Viad Corp Updates: EQT AB, DNB, CITIC Ltd Oct 21 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Monday: ** Cybersecurity firm Sophos, which is backed by private equity firm Thoma Bravo, said it will acquire Secureworks SCWX.O for $859 million in an all-cash deal to strengthen its cybersecurity offering for small, mid and enterprise customers.
M
S
U
D

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Oct 21 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 0930 GMT on Monday: ** China's state-owned CITIC Ltd 0267.HK has agreed to sell its 19.23% stake in Fast Food Holdings, the company behind McDonald's China and Hong Kong operations, to Trustar Fast Food Holdings for $430.3 million.
M
S
U

STOXX 600 finishes lower ahead of key earnings reports

UPDATE 2-STOXX 600 finishes lower ahead of key earnings reports For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Forvia jumps on supply deal with China's BYD, Xiaomi SAP, bank earnings in focus this week Updated at 1600 GMT By Paolo Laudani, Ankika Biswas and Johann M Cherian Oct 21 (Reuters) - European shares ended Monday's choppy session in the red ahead of a series of marquee corporate earnings, although stabilising oil prices buoyed
B
D
L
M
S
S
E
F
I
S
G

French and Benelux stocks-Factors to watch

French and Benelux stocks-Factors to watch Oct 21 (Reuters) - Below are company-related news and stories from France and Benelux which could have an impact on the region's markets or individual stocks. FORVIA FRVIA.PA The company on Monday posted third-quarter sales , flagging some optimism linked to its operation in China. SANOFI SASY.PA The French company said on Monday it had entered exclusive negotiations for the sale of a 50% controlling stake in its consumer health business Opella to U.S.
S
F
N
U

Sanofi in exclusive talks with CD&R over sale of $17 bln Opella

UPDATE 3-Sanofi in exclusive talks with CD&R over sale of $17 bln Opella Opella has been valued at around 16 bln euros, Sanofi says Paris given guarantees on jobs and production, sources say Sanofi increases 2024 earnings per share guidance Adds state to take a seat on board in paragraph 2, shares in 9 By Dominique Patton PARIS, Oct 21 (Reuters) - French drugmaker Sanofi SASY.PA said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella t
S

Sanofi enters exclusive talks with CD&R for Opella sale

Sanofi enters exclusive talks with CD&R for Opella sale PARIS, Oct 21 (Reuters) - Sanofi SASY.PA said on Monday it had entered exclusive negotiations for the sale of a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R). The French pharmceutical company said its Opella business has been valued at around 16 billion euros ($17.38 billion), or 14 times EBITDA in 2024, and French public investment bank Bpifrance is expected to take
S

Financial Times - Oct 21

PRESS DIGEST- Financial Times - Oct 21 Oct 21 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - Public to be asked for suggestions on how to fix NHS - French state takes stake in Sanofi unit to smooth 15.5 billion euro ($16.84 billion) deal Overview UK health secretary Wes Streeting will on Monday launch a "national conversation" about the future of the National Health Service, which he
S

REUTERS NEWS SCHEDULE AT 6 a.m SGT / 6 p.m. ET

REUTERS NEWS SCHEDULE AT 6 a.m SGT / 6 p.m. ET Here are the top stories and upcoming coverage plans for Reuters text service as of 6 a.m SGT / 6 p.m. ET. For a full schedule of news and events, go to our editorial calendar on Reuters Connect . TOP STORIES GLOBAL ISRAEL-PALESTINIANS/ Lebanese flee as Israel warns of strikes on Hezbollah financial arm BEIRUT/CAIRO (Reuters)- Hundreds of Beirut residents fled their homes late on Sunday after Israel said it was preparing attacks on sites linked to t
B
B
M
N
S
T

Sanofi reaches deal on terms of sale of consumer health arm, say French government sources

UPDATE 1-Sanofi reaches deal on terms of sale of consumer health arm, say French government sources Adds details, background PARIS, Oct 20 (Reuters) - Sanofi SASY.PA on Sunday reached an agreement on terms to sell a controlling stake in its consumer health unit Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R), French government sources said on Sunday.
S

Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI

Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI PARIS, Oct 20 (Reuters) - France will take a stake in Sanofi SASY.PA 's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro newspaper that U.S. private equity firm Clayton Dubilier & Rice (CD&R) is to take a 51% stake in the company that makes of one of France's most-sold painkillers, Doliprane.
S

France corporate earnings week ahead

DIARY-France corporate earnings week ahead Oct 18 (Reuters) - Diary of France (.FCHI) corporate earnings for the week ahead FRANCE EARNINGS Start Date Start Time(GMT) RIC Company Name Event Name 24-Oct-2024 BMO DAST.PA Dassault Systemes SE Q3 2024 Dassault Systemes SE Earnings Release 24-Oct-2024 05:30 ORAN.PA Orange SA Q3 2024 Orange SA Earnings Release 25-Oct-2024 05:30 SASY.PA Sanofi SA Q3 2024 Sanofi SA Earnings Release ** All times are listed in AMC - 'After market close', or BMO - 'Before
D
O
S
F

Financial Times - Oct 18

PRESS DIGEST- Financial Times - Oct 18 Oct 18 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines - EY slims workforce for first time in 14 years - Sanofi joins rivals investing in nuclear cancer treatment - EU considers including Elon Musk's business empire to calculate potential X fine - UK plans to place 'buy now, pay later' lenders under FCA rules - UK explores plans for new rail line as
S

Merck's RSV antibody for infants effective in reducing some types of infections in study (Oct 17)

CORRECTED-Merck's RSV antibody for infants effective in reducing some types of infections in study (Oct 17) Corrects headline, paragraph 1 and 2 in Oct. 17 story to show the drug reduced medically attended lower respiratory infections, not all lower respiratory infections Oct 17 (Reuters) - Merck MRK.N said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing some types of respiratory syncytial virus (RSV)-associated infections in infants.
A
P
S
S

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Snam, BP, Novo Nordisk, Pony AI; Updates Zuora Oct 17 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Thursday: ** BP BP.L is considering selling a minority stake in its offshore wind business, according to four sources with knowledge of the matter, the latest effort by CEO Murray Auchincloss to scale back the energy company's focus on renewables.
E
L
S
S
S
P

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds: Zuora, LVMH, PAI Partners, CSN, Sanofi, PPG Industries, Fuji Soft Oct 17 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday: ** Fuji Soft 9749.T founder and shareholder Hiroshi Nozawa said in a letter to the company, seen by Reuters, that he supports U.S.
L
S
S
P

Sanofi 'surprised' by PAI Partners' raised bid for Opella unit

UPDATE 3-Sanofi 'surprised' by PAI Partners' raised bid for Opella unit PAI Partners seeks to outbid CD&R for Opella stake Sanofi's revised bid valid until Sunday night, source says Company says new offer came outside regular process Unions fear job losses, call for strike at Sanofi's plants Updates with reaction from Sanofi to the new offer in paragraphs 1-6 PARIS, Oct 17 (Reuters) - French drugmaker Sanofi SASY.PA said on Thursday it was "surprised" by a renewed, higher offer for its consumer
S

PAI Partners makes higher offer for Sanofi's Opella, says Le Monde

PAI Partners makes higher offer for Sanofi's Opella, says Le Monde PARIS, Oct 17 (Reuters) - French private equity firm PAI Partners has submitted a new, higher offer for Sanofi's SASY.PA consumer health business Opella, the Le Monde newspaper said on Thursday, as PAI seeks to outbid U.S. rival Clayton Dubilier & Rice (CD&R). Sanofi said last week it was in talks with CD&R for the sale of a 50% stake in Opella.
S

Sanofi, Orano Join Forces To Develop Next-Generation Radioligand Medicines

BRIEF-Sanofi, Orano Join Forces To Develop Next-Generation Radioligand Medicines Oct 17 (Reuters) - Sanofi SA SASY.PA : PRESS RELEASE: SANOFI AND ORANO JOIN FORCES TO DEVELOP NEXT-GENERATION RADIOLIGAND MEDICINES SANOFI AND ORANO TO INVEST IN NEW ENTITY FOR RADIOLIGAND THERAPIES TO INVEST €300 MILLION FOR 16% STAKE IN NEW ENTITY Source text for E
S

Deals of the day-Mergers and acquisitions

Deals of the day-Mergers and acquisitions Adds Eiffage, Advent International, Manara Minerals, Saba Infraestructuras Oct 16 (Reuters) - The following bids, mergers, acquisitions, and disposals were reported by 2 000 GMT on Wednesday: * * Spanish parking operator Saba Infraestructuras will be integrated into Belgium-based Interparking after their main shareholders agreed to a merger, the companies said in a joint statement on Wednesday.
A
B
E
O
S
T
V
B

Goldman, Citi among 22 banks on CD&R’s buyout of Sanofi unit - Bloomberg News

MEDIA-Goldman, Citi among 22 banks on CD&R’s buyout of Sanofi unit - Bloomberg News -- Source link: https://tinyurl.com/kk8h626c -- Note: Reuters has not verified this story and does not vouch for its accuracy
B
B
C
G
S
S



商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明